GENERAL, O. Reg. 256/24

Schedule 1

Cite as GENERAL, O. Reg. 256/24, Schedule 1 · current to November 11, 2026 · consolidated from September 30, 2026 · read from e-Laws on November 16, 2026

The text

Schedule 1 Injected Substances Analgesics and Antipyretics Codeine — For patient education and demonstration only Hydromorphone — For patient education and demonstration only Morphine — For patient education and demonstration only Nalbuphine — For patient education and demonstration only Antibacterials Amikacin Ampicillin Cefazolin Cefepime Cefotaxime Cefoxitin Ceftazidime Ceftriaxone Clindamycin Cloxacillin Ertapenem Gentamicin Penicillin G Anticholinergic Agents Glycopyrrolate — Must not be administered intravenously Hyoscine — Must not be administered intravenously Scopolamine — Must not be administered intravenously Anticoagulants Dalteparin — Must not be administered intravenously Danaparoid — Must not be administered intravenously Enoxaparin — Must not be administered intravenously Fondaparinux — Must not be administered intravenously Heparin — For patient education and demonstration only Nadroparin — Must not be administered intravenously Tinazaparin Antidiabetic Agents Dulaglutide Exenatide Insulins Liraglutide Lixisenatide Semaglutide Tirzepatide Antihemorrhagic Agents Emicizumab Antihistamines Dimenhydrinate — Must not be administered intravenously Diphenhydramine — Only for monitoring and management of allergic reactions Antimigraine Agents Erenumab Sumatriptan Antiparkinsonian Agents Apomorphine Benztropine Antivirals Enfuvirtide Interferons Peginterferon alfa-2a Central Nervous System Agents, Miscellaneous Inotersen Complement Inhibitors Icatibant Lanadelumab Disease-modifying Antirheumatic Drugs Abatacept Adalimumab Anakinra Etanercept Golimumab — Must not be administered intravenously Methotrexate — Must not be administered intravenously Sarilumab Tocilizumab — Must not be administered intravenously Ustekinumab — Must not be administered intravenously Enzymes Asfotase Alfa GI Drugs, Miscellaneous Certolizumab Pegol Methylnaltrexone Gonadotropins and Antigonadotropins Follitropin-alpha Follitropin-beta Follitropin-delta Gonadotropin-chorionic Gonadotropin-chorionic-alfa Goserelin — For patient education and demonstration only Leuprolide — For patient education and demonstration only Lutropin-alfa Menotropins Triptorelin acetate Gonadotropin-releasing Hormone Antagonists Cetrorelix Ganirelix Heavy Metal Antagonists Deferoxamine — For patient education and demonstration only Hematopoietic Agents Darbepoetin alfa — Must not be administered intravenously Epoetin alfa — Must not be administered intravenously Filgrastim — Must not be administered intravenously Pegfilgrastim Romiplostim — For patient education and demonstration only Immunomodulatory Agents Denosumab Glatiramer Interferon-Beta-1A Interferon-Beta-1B Natalizumab Immunosuppressive Agents Belimumab — Must not be administered intravenously Mepolizumab Miscellaneous Agents Sodium Chloride Sterile Water for Injection (Diluent) Parathyroid Calcitonin Salmon — For patient education and demonstration only Teriparatide Pituitary Desmopressin — For patient education and demonstration only Vasopressin — For patient education and demonstration only Progestins Medroxyprogesterone Progesterone Prokinetic Agents Metoclopramide Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9) Inhibitors Alirocumab Evolocuma Psychotherapeutic Agents Haloperidol — For patient education and demonstration only Methotrimeprazine — For patient education and demonstration only Respiratory Tract Agents Omalizumab Skin And Mucous Membrane Agents Brodalumab Dupilumab Guselkumab Ixekizumab Risankizumab — Must not be administered intravenously Secukinumab Somatostatin Agonists and Antagonists Lanreotide Octreotide — Must not be administered intravenously Pasireotide Somatotropin Agonists and Antagonists Pegvisomant Somatropin Tesamorelin Sympatholytic (Adrenergic Blocking) Agents Dihydroergotamine — Must not be administered intravenously Vitamins Ascorbic Acid — Must not be administered intravenously Cyanocobalamin Folic Acid — Must not be administered intravenously Pyridoxine — Must not be administered intravenously Thiamine — Must not be administered intravenously Vitamin K
Read the GENERAL on e-Laws ↗

Made under Pharmacy Act, 1991, S.O. 1991, c. 36.